Matches in Nanopublications for { ?s ?p "[Sequencing of bisulfite-modified DNA within a 3,247 bp long genomic region encompassing the promoter/first exon CpG island, the coding sequence of the S100A6 gene and a downstream region showed that it is almost entirely methylation-free in S100A6 expressing human epidermoid carcinoma (Hep-2) cells and lymphocytes and methylated in S100A6-negative embryonic epithelial (HEK293) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP183909.RAuw78b2C8iYZvJFcLQwc3brcfxHQk0iXP84vo8adKBps130_assertion description "[Sequencing of bisulfite-modified DNA within a 3,247 bp long genomic region encompassing the promoter/first exon CpG island, the coding sequence of the S100A6 gene and a downstream region showed that it is almost entirely methylation-free in S100A6 expressing human epidermoid carcinoma (Hep-2) cells and lymphocytes and methylated in S100A6-negative embryonic epithelial (HEK293) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183909.RAuw78b2C8iYZvJFcLQwc3brcfxHQk0iXP84vo8adKBps130_provenance.
- NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_assertion description "[Sequencing of bisulfite-modified DNA within a 3,247 bp long genomic region encompassing the promoter/first exon CpG island, the coding sequence of the S100A6 gene and a downstream region showed that it is almost entirely methylation-free in S100A6 expressing human epidermoid carcinoma (Hep-2) cells and lymphocytes and methylated in S100A6-negative embryonic epithelial (HEK293) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678291.RATPF8VB4Ki9RrgOJtEOOjEW9qdwrXtR2HM-MyeRB63X0130_provenance.
- assertion description "[Sequencing of bisulfite-modified DNA within a 3,247 bp long genomic region encompassing the promoter/first exon CpG island, the coding sequence of the S100A6 gene and a downstream region showed that it is almost entirely methylation-free in S100A6 expressing human epidermoid carcinoma (Hep-2) cells and lymphocytes and methylated in S100A6-negative embryonic epithelial (HEK293) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP609426.RABy7tl4UnnaS3aroTyPhd-2hIHcsryIRi6E10j0J9kvk130_assertion description "[Sequencing of bisulfite-modified DNA within a 3,247 bp long genomic region encompassing the promoter/first exon CpG island, the coding sequence of the S100A6 gene and a downstream region showed that it is almost entirely methylation-free in S100A6 expressing human epidermoid carcinoma (Hep-2) cells and lymphocytes and methylated in S100A6-negative embryonic epithelial (HEK293) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609426.RABy7tl4UnnaS3aroTyPhd-2hIHcsryIRi6E10j0J9kvk130_provenance.